Ignite Creation Date:
2024-05-06 @ 2:20 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04284202
Status:
UNKNOWN
Last Update Posted:
2020-02-25
First Post:
2020-02-23
Brief Title:
PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC
Sponsor:
The Affiliated Hospital of Qingdao University
Organization:
The Affiliated Hospital of Qingdao University
Organization Data
Organization:
The Affiliated Hospital of Qingdao University
Class:
OTHER
Study ID:
IOT-ARID1A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Lead Sponsor Class:
OTHER
Responsible Party:
zhangxiaochun
Responsible Party Title:
Director of Precision Medicine Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The Affiliated Hospital of Qingdao University
Old Name:
None
Old Organization:
None